Epidiolex

The majority of caregivers of patients with tuberous sclerosis complex (TSC) say they plan to continue Epidiolex treatment, citing benefits like reduced seizure frequency and improvements in cognition and communication. That's according to data from the BECOME-TSC (BEhavior, COgnition, and More...

Jazz Pharmaceuticals (NASDAQ:JAZZ) reported results from a Phase 3 trial in Japan evaluating the safety and efficacy of cannabidiol oral solution, Epidiolex, for treating seizures in children with rare forms of epilepsy, such as Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis...

Phytanix Bio, a preclinical stage pharmaceutical company, has released an updated investor deck. The presentation showcases a business strategy aimed at developing new cannabinoid-based pharmaceuticals. The company, which has ties to historical pharmaceutical developments in the cannabis industry,...

Chain Bridge I (NASDAQ:CBRG) announced on Monday the acquisition of Phytanix Bio, a pharmaceutical company specializing in the development of therapeutics based on cannabinoid and cannabinoid-like molecules. The transaction, valued at $58 million, also includes the assumption of preferred stock and...

Cannabinoid-focused biopharmaceutical company Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) announced on Thursday that it has completed the commercial export of Aureus-branded purified cannabigerol (CBG) products into Singapore through its majority-owned subsidiary Santa Marta Golden Hemp. The...

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). This shift could revolutionize the cannabis industry. But what exactly is Schedule III? What other substances are produced and studied in this...

If there's love that could move the Earth, it's that of a parent towards a child. And, as the Chinese proverb says, ‘To understand your parent's love, you must raise children yourself.' Today's story is about a mother who once moved mountains for her daughter and continues...

Around 8% of Australians are using medical marijuana either occasionally or regularly, according to a recent survey of 1,000 participants conducted by consumer insights company Antenna, reported Cannabiz. The Medigrowth-commissioned study revealed that 22% of respondents either contemplated or...

In groundbreaking research published this month in the Journal of Dental Research, scientists from Rutgers University and the University of Texas revealed that CBD, a cannabis compound could offer a potent and safe alternative to opioids for managing acute dental pain. According to...

Medical Cannabis-Based Epidiolex Advances Through Japan's Legislature Earlier this week, Japanese policymakers gave the green light to a measure to legalize medical products derived from cannabis, simultaneously emphasizing the country's existing restrictions on the use of other...

Researchers with the Food and Drug Administration (FDA) reported Wednesday on the agency’s 50 years of experience with marijuana research. In an article titled “FDA’s 50 Years of Experience with Cannabis Research Helping to Support Tomorrow’s Cannabis Drug...

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced its financial results for the second quarter of 2023, along with its outlook for the remainder of the year. Financial Highlights GAAP net income for Q2 2023 stood at $104.4 million, reflecting an increase from $34.7 million in the same period...

Is the battle for medical marijuana legalization in North Carolina over for this year? Some groups say yes, some say no. Here is what happened. Smart Approaches to Marijuana (SAM), an organization opposed to marijuana legalization, said on Friday that North Carolina “...

Unexpected falls, stiff muscles, dazed behavior, memory gaps, mumbling or no response, sudden bursts of anger and fear are all symptoms of epilepsy, which is one of the most common childhood brain disorders. Now imagine your own child having up to 300 seizures a day. That's the...

The U.S. Food and Drug Administration has not given up on regulating CBD and hemp-derived products in a way that would be safe for consumers and producers. Last week, the administration held a virtual panel “A New Way Forward for Cannabidiol and Other Hemp Products” for ...